Drs. Acne Spot Treatment

Description

This product is indicated for the treatment of acne. It is formulated specifically for application to localized areas of acne lesions. The active ingredients work to reduce inflammation and promote healing of the affected skin. The dosage form is designed for topical use, ensuring targeted delivery to the site of application. The formulation may include various excipients to enhance stability and skin compatibility.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively dries and clears acne pimples, blackheads, and whiteheads, facilitating the healing of the skin.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Following a thorough cleansing of the skin, acne clear gel should be applied locally to cutaneous imperfections in the morning and evening. After the application of the gel, the usual day or night cream may be applied. The gel can be reapplied 1 to 3 times daily, depending on the severity of the condition and the patient's response to treatment.

Contraindications

Use is contraindicated in individuals with sensitive skin or those who are sensitive to salicylic acid. Due to the potential for adverse reactions, this product should not be administered to these patients.

Warnings and Precautions

For external use only. The concurrent use of other topical acne medications may exacerbate skin dryness or irritation. In such cases, it is advised that only one medication be utilized unless otherwise directed by a healthcare professional. Direct contact with the eyes should be avoided; in the event of accidental exposure, the eyes should be rinsed thoroughly with water. Should skin irritation develop or worsen, discontinuation of the product is recommended, and if irritation persists, consultation with a healthcare provider is warranted.

In the event of accidental ingestion, immediate medical assistance should be sought, or the poison control center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. The concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin. In the event that skin irritation develops or worsens, it is advised to discontinue use immediately. Should the irritation persist, consultation with a healthcare professional is recommended.

Additionally, care should be taken to avoid direct contact with the eyes. If the product inadvertently comes into contact with the eyes, it is important to rinse the area liberally with water to mitigate any potential adverse effects.

Drug Interactions

Concurrent use of other topical acne medications with this product may lead to increased dryness or irritation of the skin. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and skin health.

Packaging & NDC

Below are the non-prescription pack sizes of Drs. Acne Spot Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the poison control center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no available data regarding its use during pregnancy. As such, the safety of this product in pregnant individuals remains undetermined. No specific safety concerns have been identified in the prescribing information, and there are no recommended dosage modifications for pregnant individuals. Additionally, no special precautions regarding the use of this product during pregnancy are provided. Healthcare professionals should weigh the potential benefits against any unknown risks when considering this product for women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Overall, vigilance and prompt intervention are critical in managing any suspected overdose effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a poison control center if the product is swallowed. It is important to discuss the potential for skin sensitivity, particularly for those who have a history of sensitivity to salicylic acid. Patients should be instructed to avoid contact with the eyes, lips, and mouth to prevent irritation or adverse reactions.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30°C (59-86°F) to maintain its efficacy. After each use, the cap should be closed tightly to prevent contamination and ensure product integrity. Additionally, the product must be kept away from heat sources to avoid degradation. Proper handling and storage conditions are crucial for preserving the quality of the product.

Additional Clinical Information

The product is administered topically, with patients advised to apply the acne clear gel locally on cutaneous imperfections after thorough cleansing of the skin. This application should occur in the morning and evening, with the option to renew the application 1 to 3 times daily. Following the gel application, patients may apply their usual day or night cream.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Drs. Acne Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)